Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2018-02-21 | 2019-05-28 | 40420 |
| TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2021-03-04 | 2022-04-21 | 135138 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-07-29 | 2022-04-28 | 143236 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-01-12 | 2023-06-09 | 180878 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-07-18 | 2024-03-18 | 199092 |
| TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-10-05 | 2023-10-19 | 206404 |
| TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-11-03 | 2024-05-09 | 209108 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2020-03-06 | 2020-03-26 | 108027 |
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2020-09-11 | 2020-12-17 | 124101 |
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2021-02-25 | 2021-05-20 | 134730 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Actual shortage | 2021-08-27 | 2022-08-18 | 144701 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9922 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9939 |
| TEVA-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-09-27 | 2018-10-12 | 62458 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-09-05 | 2020-01-24 | 93172 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-04-23 | 2020-08-27 | 113010 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-09-17 | 2020-12-17 | 124468 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2018-06-15 | 2019-05-28 | 52485 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-06-15 | 2018-11-08 | 52488 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |